Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $96

Author: Benzinga Newsdesk | August 04, 2025 10:36am
Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $104 to $96.

Posted In: CL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist